Search details
1.
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.
Breast Cancer Res Treat
; 205(2): 267-279, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38453781
2.
RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire.
BMC Cancer
; 23(1): 679, 2023 Jul 20.
Article
in English
| MEDLINE | ID: mdl-37468859
3.
Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial.
BMC Cancer
; 23(1): 621, 2023 Jul 04.
Article
in English
| MEDLINE | ID: mdl-37400806
4.
Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol).
BMC Cancer
; 23(1): 344, 2023 Apr 15.
Article
in English
| MEDLINE | ID: mdl-37060055
5.
Body Mass Index, Sarcopenia, and Their Variations in Predicting Outcomes for Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma.
Oncology
; 100(2): 114-123, 2022.
Article
in English
| MEDLINE | ID: mdl-34999587
6.
Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol.
BMC Cancer
; 22(1): 417, 2022 Apr 15.
Article
in English
| MEDLINE | ID: mdl-35428211
7.
Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition.
Genes Chromosomes Cancer
; 60(2): 73-78, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33099839
8.
Preoperative stereotactic radiosurgery for brain metastases: the STEP study protocol for a multicentre, prospective, phase-II trial.
BMC Cancer
; 21(1): 864, 2021 Jul 28.
Article
in English
| MEDLINE | ID: mdl-34320940
9.
Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
BMC Cancer
; 21(1): 360, 2021 Apr 07.
Article
in English
| MEDLINE | ID: mdl-33827483
10.
Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial.
Respir Res
; 21(1): 129, 2020 May 25.
Article
in English
| MEDLINE | ID: mdl-32450847
11.
A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
BMC Cancer
; 20(1): 730, 2020 Aug 05.
Article
in English
| MEDLINE | ID: mdl-32758188
12.
A decrease in brown adipose tissue activity is associated with weight gain during chemotherapy in early breast cancer patients.
BMC Cancer
; 20(1): 96, 2020 Feb 04.
Article
in English
| MEDLINE | ID: mdl-32019525
13.
A high expression ratio of RhoA/RhoB is associated with the migratory and invasive properties of basal-like Breast Tumors.
Int J Med Sci
; 17(17): 2799-2808, 2020.
Article
in English
| MEDLINE | ID: mdl-33162807
14.
Treatment-Induced Cardiotoxicity in Breast Cancer: A Review of the Interest of Practicing a Physical Activity.
Oncology
; 96(5): 223-234, 2019.
Article
in English
| MEDLINE | ID: mdl-30943496
15.
The efficacy of immune checkpoint inhibitors following discontinuation for long-term response or toxicity in advanced or metastatic non-small-cell lung cancers: A retrospective study.
Health Sci Rep
; 7(1): e1825, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38274141
16.
Non-invasive intracranial pressure monitoring for high-grade gliomas patients treated with radiotherapy: results of the GMaPIC trial.
Front Oncol
; 14: 1302977, 2024.
Article
in English
| MEDLINE | ID: mdl-38919520
17.
A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC?
Cancer Chemother Pharmacol
; 93(3): 225-236, 2024 03.
Article
in English
| MEDLINE | ID: mdl-37932443
18.
Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplanar arcs and acute toxicity outcomes from the STEREOPOSTOP GORTEC 2017-03 phase 2 trial.
Clin Transl Radiat Oncol
; 38: 169-174, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36466746
19.
Imaging quality of an artificial intelligence denoising algorithm: validation in 68Ga PSMA-11 PET for patients with biochemical recurrence of prostate cancer.
EJNMMI Res
; 13(1): 50, 2023 May 25.
Article
in English
| MEDLINE | ID: mdl-37231229
20.
Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy.
Front Oncol
; 13: 1272856, 2023.
Article
in English
| MEDLINE | ID: mdl-38023128